762286-15-7 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
Ethanone, 1-[1-[(3S)-3-hydroxy-1-pyrrolidinyl]-4,4-dimethylcyclohexyl]is utilized as a key component in the development of pharmaceuticals targeting central nervous system disorders. Its unique structure and functional groups allow it to interact with biological targets, potentially leading to therapeutic effects in treating such conditions.
Used in Pain Management:
In the field of pain management, Ethanone, 1-[1-[(3S)-3-hydroxy-1-pyrrolidinyl]-4,4-dimethylcyclohexyl]- serves as an active ingredient or a precursor in the synthesis of analgesic drugs. Its ability to modulate pain pathways and receptors makes it a promising candidate for the development of novel pain relief medications.
Used in the Development of CNS Disorder Treatments:
Ethanone, 1-[1-[(3S)-3-hydroxy-1-pyrrolidinyl]-4,4-dimethylcyclohexyl]is also applied in the research and development of treatments for central nervous system disorders. Its potential to influence neurotransmission and neuronal function positions it as a candidate for the treatment of various neurological conditions.
Used in Chemical Synthesis:
Beyond its direct applications, Ethanone, 1-[1-[(3S)-3-hydroxy-1-pyrrolidinyl]-4,4-dimethylcyclohexyl]- is also used as an intermediate in the synthesis of other complex organic molecules, contributing to the advancement of chemical libraries and the discovery of new drugs with diverse therapeutic potentials.
Check Digit Verification of cas no
The CAS Registry Mumber 762286-15-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,2,2,8 and 6 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 762286-15:
(8*7)+(7*6)+(6*2)+(5*2)+(4*8)+(3*6)+(2*1)+(1*5)=177
177 % 10 = 7
So 762286-15-7 is a valid CAS Registry Number.
762286-15-7Relevant academic research and scientific papers
MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISTS AND COMPOSITIONS AND METHODS RELATED THERETO
-
Page 127, (2010/02/08)
Melanin-concentrating hormone (MCH) receptor antagonists are disclosed having utility for the treatment of MCH receptor-based disorders such as obesity. The compounds of this invention have the following structure: including stereoisomers, prodrugs, and pharmaceutically acceptable salts thereof, wherein m, n, X, R1, R2, R3, R4, and R5 are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.
